May 2012 FDA Recall Drug by Endo Pharmaceuticals, Inc.
D-1381-2012 - Adulterated Presence of Foreign Tablets

This Class III drug recall was voluntarily initiated by Endo Pharmaceuticals, Inc. on May 7, 2012 for the product Drug. The FDA reported the reason for recall as adulterated presence of foreign tablets. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1381-2012

Reason for Recall
Adulterated Presence of Foreign Tablets: Customer complaint that some Endocet 10 mg/325 mg tablets were found mixed in a bottle with Endocet 10 mg/650 mg tablets.
Initiated
05-07-2012
Reported
06-20-2012
Quantity
11,764 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Endo Pharmaceuticals, Inc.
Nationwide and Puerto Rico
Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, 100-count tablets per bottle, Rx only, Manufactured for: Endo Pharmaceuticals Inc., Chadds Ford, PA, By: Novartis, Lincoln, NE 68501; NDC 60951-797-70.

Batch or Lot Expiration Information

Lot# : 402794NV, Exp 12/13